Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3

NCT07465926 · clinicaltrials.gov ↗

COMPLETED

Status

451036

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular-kidney-metabolic Syndrome
Cardiovascular Disease Risk Factor
Kidney Disease
Type 2 Diabetes
Obesity & Overweight

Interventions

DRUG: GLP-1 receptor agonist
DRUG: SGLT2 inhibitor

Sponsor

Chung Shan Medical University

Collaborators

[object Object]